Prescription to Nonprescription Switch List

This list only includes nonprescription drug products that have undergone a prescription-to-nonprescription (Rx-to-NonRx) switch in marketing status — just one of several ways to bring a nonprescription drug to market in the US. The list includes both full and partial switches from prescription to nonprescription marketing status.

Additional information about drug application pathways

• New Drug Application (NDA)
• Abbreviated New Drug Application (ANDA)
• Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU)

For information on available nonprescription drug products brought to market via an NDA or ANDA drug application pathway, visit either Drugs@FDA or the Orange Book.